GulfDrug’s history has been tied with the early history of healthcare in the UAE since its inception, providing for hospitals, clinics, pharmacies and other institutions in all of the UAE. GulfDrug was established in 1969, initially starting as a pharmaceutical importer then branching into other medical categories and has since then progressed side by side with the development, growth and maturity of the various health institutions in the UAE.
.png)
New Country Healthcare (NCH) was founded in 1978 as Country Pharmacy and evolved to New Country Healthcare in 1990, NCH today is a leader in the healthcare sector, with a rich portfolio that includes over 1500 products manufactured in United States, Canada, Europe, Asia and Middle East. NCH started with a vision of a healthier community by our Chairman Dr. Ghazi Al Koudsi, a UAE board certified pharmacist and consultant to governing agencies. With hard work and dedication, NCH has not only kept their promise to the community but, has also stayed true to the vision of our chairman who inspires every member of the NCH family to give their best every day.
We are an international group based in Parma, research-oriented, with over 85 years of experience, present in 30 countries. The Chiesi Group researches, develops and markets innovative drugs in three specific areas: AIR (products and services in the respiratory field, from infants to adults), RARE (innovative solutions and personalized services to improve the quality of life of patients with rare and ultra-rare diseases) and CARE (products and services to support specialist care, personal care and well-being). Since 2019 we are a certified B Corp, while, in 2018, we changed our legal status to a Benefit Company, realizing the desire to measure our impact on society and the environment, combining the need to generate value for the business to acting as a positive force for the community in which we live.
AbbVie was founded in 2013 when we became a separate company from Abbott. Our name represents a proud connection to that legacy. AbbVie formed a new kind of enterprise – a biopharmaceutical company – with the stability, global scale, resources and commercial capabilities of a pharmaceutical company and the focus and culture of a biotech. Since the beginning, our mission hasn't wavered. Our combination of focused innovation and commercial scale brings differentiated products to market that benefit patients, customers and health care providers.  Our mission is to discover and deliver innovative medicines and products that solve serious health issues and enhance people’s lives today and address the medical challenges of tomorrow.